After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. After-hours trades for ARS Pharmaceuticals Inc (SPRY) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.03, or -0.71%, to $4.20. The ARS Pharmaceuticals Inc has recorded 6,483 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted ARS Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Updates.
SPRY belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $4.23 and fluctuated between $4.2848 as its day high and $4.0200 as its day low. The current market capitalization of ARS Pharmaceuticals Inc is $406.08M. A total of 0.74 million shares were traded on the day, compared to an average of 1.34M shares.
Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, SPRY has seen 9 BUY and 1 SELL insider trades, representing the acquisition of 7,636,258 and the disposition of 100,000 shares. Over the last 12 months, there were 22 BUYs and 13 SELLs from insiders. Insiders purchased 8,044,508 shares during that period but sold 500,000.
In the most recent transaction, Fitzpatrick Alexander A bought 46,258 shares of SPRY for 3.78 per share on Sep 29. After the transaction, the Chief Legal Officer now owns 89,227 company shares. In a previous transaction on Sep 28, Fitzpatrick Alexander A bought 40,000 shares at 3.62 per share. SPRY shares that Chief Legal Officer owns now total 42,969.
Among the insiders who bought shares, RA CAPITAL MANAGEMENT, L.P. acquired of 2,700,000 shares on Sep 21 at a per-share price of $3.03. This resulted in the Director holding 8,556,774 shares of SPRY after the transaction. In another insider transaction, Shawver Laura sold 100,000 shares at $7.71 per share on Sep 01. Company shares held by the Director now total 210,346.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for SPRY in the last 3 months, the mean price target is $8.00 with high estimates of $13.00 and low estimates of $3.00. In terms of 52-week highs and lows, SPRY has a high of $9.65 and a low of $2.55.
As of this writing, SPRY has an earnings estimate of -$0.14 per share for the current quarter. EPS was calculated based on a consensus of 3 estimates, with a high estimate of -$0.1 per share and a lower estimate of -$0.17. The company reported an EPS of -$0.18 in the last quarter, which was -5.90% lower than expectations of -$0.17.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SPRY’s latest balance sheet shows that the firm has $60.06M in Cash & Short Term Investments as of fiscal 2021. There were $9.03M in debt and $8.19M in liabilities at the time. Its Book Value Per Share was $2.48, while its Total Shareholder’s Equity was -$31.27M.
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SPRY is Buy with a score of 3.67.